Graph Therapeutics

Berlin AI x Bio Meetup · Luma Graph Therapeutics, Merantix Capital, and TechBio Transformers (TBT) are bringing together techbio enthusiasts and experts in Berlin for a meetup, timed…

​You’re invited to join us for an evening to connect with others building at the intersection of biology, technology, and AI:

📅 19 November 2025, 18:30
📍 Merantix AI Campus, Berlin
👉 Sign up: lu.ma/u4i3i1i3

We’re excited to see you there and to talk about the future of techbio with you! 💡⚙️

By laying the groundwork with this collaboration, we’ll be able to continue to drive techbio innovation and create new opportunities that can transform how therapies are developed for patients with immune-mediated diseases worldwide. 🚀🌟

This partnership combines our AI-driven lab-in-the-loop approach with BIIE’s immune engineering expertise. By sharing resources, data, & insights, the goal is to jointly bridge the gap between lab discoveries & clinical impact, addressing critical unmet needs in the inflammation & immunology space.

✨ Some exciting news: We’re announcing a strategic partnership with the Botnar Institute of Immune Engineering (BIIE) to accelerate the development of precision medicines for immune-mediated diseases!

To learn more, reach out for a meeting or drop by our presentation:

📅 When: 5 November, 10:40
🎤 Speaker: Gregory Vladimer
📍 Where: Presenting Company Theater 1

Meet the Graph team at #BIOEurope in Vienna from 3 - 5 November! We’ll be sharing how Graph is leading the way towards precision immunology drug discovery and development through capturing, mapping, and predicting patient immune dysfunction at scale.

Meet the team behind Graph and say hello to Desy Vallorani, Research Associate! 🚢🔬

With Desy’s help, we’re generating high-quality and contextually rich datasets for complex immune diseases. ➕✖️

Salut Lausanne 🇨🇭, Graph’s Senior Research Scientist Rin Okumura will be at the 2nd Symposium on the Immunobiology of Pattern Recognition Receptors hosted by @unil.bsky.social from 1 - 2 October! We’re excited to explore and discuss the latest discoveries in innate immune research. 💪 🧬

👏A big thank you to the AITHYRA symposium organizers for a fantastic 3-days of scientific conversation and connection!

@gregvladimer.bsky.social, Aishwarya Parthasarathy, Nathan Benaich, and @georgwinter.bsky.social wrapped up the final session of the @aithyra.bsky.social symposium with a panel discussion about building AI-first spinouts and ventures, and how to improve science & tech collaborations. 🚀✨

How can we best drive ideation, funding, and operation of academic-spin outs and academically linked ventures that span interdisciplinary fields, while keeping the end goal of patient success in mind? 💡⚙️

From our team, @gregvladimer.bsky.social, @rogepese.bsky.social, Bojan Vilagos, and @izepb.bsky.social will be attending the symposium. Come by and say hi! 👋

On 10 September, @gregvladimer.bsky.social will be chairing the final session of the symposium, and will participate as part of a round table on techbio spin outs, fundraising and commercialization. 💡

Hey Vienna 🇦🇹, Graph will be at the @aithyra.bsky.social Symposium “AI for Life Science” from 8 - 10 September! We’re looking forward to attending many of the talks by an outstanding line up of speakers. Let us know if you’re around and let’s talk! 💬 ☕

Meet the team behind Graph and say hello to Christophe Boudesco, VP Immunology! 👋 🥼

Better algorithms and better biological validations go hand in hand. The expertise that Christophe brings will help the team at Graph reduce biological uncertainty early and systematically. ➕✖️

Servus Vienna! 🇦🇹 Christophe Boudesco, Graph’s VP Immunology, will be at the 19th International Congress of Immunology (IUIS 2025) in Vienna from 17 - 22 August. Let us know if you’ll be around and let’s talk translational immunology! 🔬🧬

With its strong academic network & public-private partnerships, Vienna takes a leading role in shaping the bio x AI ecosystem. We're excited to be a part of this and to help it grow! 🌿

Great read about the history & scope of biotech in the 🇦🇹 capital. Check it out! ➡️ www.labiotech.eu/in-depth/vie...

Precision immunology requires precision data After a decade iterating on AI drug discovery platforms from Allcyte/Exscientia to Graph, precision medicine demands active investment in data, biological context, and repeated experimental validation

After a year of building again in the techbio space, the Graph co-founders have written a deep dive on why precision medicine requires precision data.

➡️ Check it out: graphtx.substack.com/p/precision-...

Meet the team behind Graph and say hello to @kdris.bsky.social, Head of AI! 👋 🦜

Target discovery in immunology is a complex process. Bringing together individuals who have deep knowledge in adjacent domains helps us approach the challenges from multiple angles. ➕✖️

Happy 1st bday, Graph! 🎈 We've gone from an idea to a team of 11 (recruiting #12!), building lab-in-the-loop infrastructure, fueled by $5M in funding & academic collabs. We had a great time celebrating our journey with the team & reflecting on our mission to rebalance dysregulated immune systems! ➕✖️

We're hiring! 📢

Our team is looking for a Quantitative Systems Biologist driving research at the interface of computational and lab biology. 🧪🥼🔍

Want to know more? Reach out to us and apply via the link below! ⬇️

www.linkedin.com/jobs/view/42...

Poster with a portrait photo of Daniel Thomas, MLOps & data engineer for Graph Therapeutics.

Meet the team behind Graph and say hello to Daniel Thomas, MLOps & data engineer! 👋 💬

We’re excited to have you along for the journey! Here’s to discovering better therapeutics for immune-mediated diseases by bridging the gap between biology and machine learning. ➕✖️

#123, Decoding Immune Cell Behavior to Transform Treatment Discovery with Gregory Vladimer from Graph Therapeutics Graph Therapeutics combines AI-driven perturbation modeling with multi-omics data to develop targeted therapies for patients with complex immune-mediated diseases who currently lack effective treatmen...

💡How are we using disease perturbational modeling & AI to transform the treatment of immunological diseases? In the AWS Health podcast, Graph's co-founder & CEO @gregvladimer.bsky.social talks science, tech, & where the future is headed in target discovery.

🎧 Check out the podcast! ➡️ bit.ly/43b5LAw

Excited to be joining the panel discussion later today! ✨

Mark your calendars! 📅 The @WiMLWorkshop Social returns to @iclrconf!

🗓️ Friday, April 25th, 2025
⏰ 12:30 PM - 2:00 PM
📍 Hall 1 Apex, Singapore Expo
iclr.cc/virtual/2025...

lu.ma/ftdnjnf9

#ICLR2025

Poster of news from Graph Therapeutics, the Graph Therapeutics logo in the top right corner, with the headline in the center that reads: Graph Therapeutics awarded EUR 1.1M Deep Tech Seed Financing from the Austria Wirtschafts Service (AWS). A logo of the AWS in on the bottom left hand corner.

A poster of a new story from Graph Therapeutics, with the Graph Therapeutics logo in the top right corner. The body text reads: "Graph has been awarded the Deep Tech Life Science Seed Financing grant from the AWS, an Austrian government program that supports techbio projects based on applied research and development. This program helps advance Graph’s clinically realistic precision immunology platform." The AWS logo is in the bottom right hand corner.

Graph receives the Deep Tech Life Science Seed Financing grant from the Austria Wirthschafts Service (AWS) worth EUR 1.1M! This accelerates our AI-driven platform technology and lab-in-the-loop approach to discover better data, targets, validation & biomarkers for immune & inflammatory diseases. 🎯🧬

Graph at ICLR 2025 in Singapore from 24 - 28 April. Meet us there!

A portrait of Katherine Driscoll, Head of AI at Graph, standing in front of a blackboard with mathematical formulas.

Hey Singapore, @kdris.bsky.social will be at ICLR 2025 from 24 - 28 April! We’re looking forward to hearing about the latest discoveries in biology, AI, and deep learning. Let us know if you’ll be around! 🇸🇬

Just came back from the IRB conference in Barcelona on BioxAI. Still amazed by the speed at which (Gen)AI is already transforming comp bio research. Had fun catching up with familiar faces and made new connections. Huge thanks to the organisers for putting up cool program with top-notch line ups!

Portrait of Professor Berend Snijder with a blue button-down shirt against a blurred concrete background.

📣 Congratulations to Graph scientific co-founder Berend Snijder on his new appointment as Faculty Professor and Research Group Leader at the Botnar Institute of Immune Engineering (BIIE)! Here’s to even more groundbreaking work and discoveries. 🥂💥

➡️ Read more: immune.engineering/news/dr-bere...

A poster for Graph at the AI in Drug Discovery and Biomedicine conference in Barcelona, Spain from 31 March to 2 April, 2025.

A photo of Ize Buphamalai, Principal Scientist at Graph.

¡Hola! 🇪🇸 We’re looking forward to seeing everyone at the @irbbarcelona.org for the AI in Drug Discovery and Biomedicine conference. If you’re around, reach out to @izepb.bsky.social and let's meet up! 👋

Graph CEO Gregory Vladimer stands at a podium in the center of the BIO-Europe Spring presentation stage with the introductory slide to Graph in the background.

We're back on the circuit at BIO-Europe Spring in Milan! ☕ 🇮🇹
@gregvladimer.bsky.social kicked off the 2nd day with a presentation about Graph, specifically how we combine complex immunological models, multi-modal data, and AI to tackle the drug discovery complexities of immune-mediated diseases. 👏